These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

184 related articles for article (PubMed ID: 9180079)

  • 1. Peptide agonist of the thrombopoietin receptor as potent as the natural cytokine.
    Cwirla SE; Balasubramanian P; Duffin DJ; Wagstrom CR; Gates CM; Singer SC; Davis AM; Tansik RL; Mattheakis LC; Boytos CM; Schatz PJ; Baccanari DP; Wrighton NC; Barrett RW; Dower WJ
    Science; 1997 Jun; 276(5319):1696-9. PubMed ID: 9180079
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Peptide agonists of the thrombopoietin receptor.
    Dower WJ; Cwirla SE; Balasubramanian P; Schatz PJ; Baccanari DP; Barrett RW
    Stem Cells; 1998; 16 Suppl 2():21-9. PubMed ID: 11012174
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A non-peptide compound which can mimic the effect of thrombopoietin via c-Mpl.
    Kimura T; Kaburaki H; Tsujino T; Ikeda Y; Kato H; Watanabe Y
    FEBS Lett; 1998 May; 428(3):250-4. PubMed ID: 9654143
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Thrombopoietin and the humoral regulation of thrombocytopoiesis.
    Eaton DL; de Sauvage FJ
    Curr Opin Hematol; 1995 May; 2(3):167-71. PubMed ID: 9371990
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone marrow stromal cells produce thrombopoietin and stimulate megakaryocyte growth and maturation but suppress proplatelet formation.
    Nagahisa H; Nagata Y; Ohnuki T; Osada M; Nagasawa T; Abe T; Todokoro K
    Blood; 1996 Feb; 87(4):1309-16. PubMed ID: 8608219
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thrombocytopenia in c-mpl-deficient mice.
    Gurney AL; Carver-Moore K; de Sauvage FJ; Moore MW
    Science; 1994 Sep; 265(5177):1445-7. PubMed ID: 8073287
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Discovery of a novel thrombopoietin mimic agonist peptide.
    Kimura T; Kaburaki H; Miyamoto S; Katayama J; Watanabe Y
    J Biochem; 1997 Nov; 122(5):1046-51. PubMed ID: 9443823
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Thrombopoietin (Mpl ligand) and the regulation of platelet production.
    Cohen-Solal K; Debili N; Vainchenker W; Wendling F
    Eur Cytokine Netw; 1997 Sep; 8(3):311-4. PubMed ID: 9346371
    [No Abstract]   [Full Text] [Related]  

  • 9. Expression of the receptor MPL and proliferative effects of its ligand thrombopoietin on human leukemia cells.
    Quentmeier H; Zaborski M; Graf G; Ludwig WD; Drexler HG
    Leukemia; 1996 Feb; 10(2):297-310. PubMed ID: 8637239
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Hematopoietic growth factor mimetics.
    Kaushansky K
    Ann N Y Acad Sci; 2001 Jun; 938():131-8. PubMed ID: 11458500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thrombopoietin: understanding and manipulating platelet production.
    Kaushansky K
    Annu Rev Med; 1997; 48():1-11. PubMed ID: 9046940
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tyrosine 462 of the membrane-proximal F'-G' loop of murine Mpl is not essential for high-affinity binding of thrombopoietin.
    Sabath DF; Lin N; Sabath DE; Kaushansky K; Broudy VC
    Cytokine; 2000 Feb; 12(2):127-33. PubMed ID: 10671297
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Discovery and characterization of a selective, nonpeptidyl thrombopoietin receptor agonist.
    Erickson-Miller CL; DeLorme E; Tian SS; Hopson CB; Stark K; Giampa L; Valoret EI; Duffy KJ; Luengo JL; Rosen J; Miller SG; Dillon SB; Lamb P
    Exp Hematol; 2005 Jan; 33(1):85-93. PubMed ID: 15661401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. c-mpl, the thrombopoietin receptor.
    Vainchenker W; Methia N; Debili N; Titeux M; Wendling F
    Thromb Haemost; 1995 Jul; 74(1):526-8. PubMed ID: 8578519
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Recombinant human c-Mpl ligand (thrombopoietin) not only acts on megakaryocyte progenitors, but also on erythroid and multipotential progenitors in vitro.
    Tanimukai S; Kimura T; Sakabe H; Ohmizono Y; Kato T; Miyazaki H; Yamagishi H; Sonoda Y
    Exp Hematol; 1997 Sep; 25(10):1025-33. PubMed ID: 9293899
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Cloning and expression of murine thrombopoietin cDNA and stimulation of platelet production in vivo.
    Lok S; Kaushansky K; Holly RD; Kuijper JL; Lofton-Day CE; Oort PJ; Grant FJ; Heipel MD; Burkhead SK; Kramer JM
    Nature; 1994 Jun; 369(6481):565-8. PubMed ID: 8202158
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Platelets release thrombopoietin (Tpo) upon activation: another regulatory loop in thrombocytopoiesis?
    Folman CC; Linthorst GE; van Mourik J; van Willigen G; de Jonge E; Levi M; de Haas M; von dem Borne AE
    Thromb Haemost; 2000 Jun; 83(6):923-30. PubMed ID: 10896250
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dissecting the thrombopoietin receptor: functional elements of the Mpl cytoplasmic domain.
    Drachman JG; Kaushansky K
    Proc Natl Acad Sci U S A; 1997 Mar; 94(6):2350-5. PubMed ID: 9122198
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Signaling by the Mpl receptor involves IKK and NF-kappaB.
    Zhang Y; Sun S; Wang Z; Thompson A; Kaluzhny Y; Zimmet J; Ravid K
    J Cell Biochem; 2002; 85(3):523-35. PubMed ID: 11967992
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Platelets exposed to elevated levels of endogenous thrombopoietin in vivo have a reduced response to megakaryocyte growth and development factor in vitro.
    Nishiyama U; Morita H; Torii Y; Kuwaki T; Shimizu E; Akahori H; Kato T; Miyazaki H
    Thromb Haemost; 2001 Jan; 85(1):152-9. PubMed ID: 11204567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.